Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04534517 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 11
- Study locations
NCT04534517: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
NCT04534517 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 119 participants, below the 134-participant average among 20 other Visual Acuity trials with a reported enrollment target (11% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04534517, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 11
- Study locations
Study Summary
The clinical study is a bilateral, single-masked (partial), single-arm, clinical trial. A total of approximately 60 eligible subjects both near-sighted and far-sighted, will be targeted to complete the study. Subjects will be fit in the study lens for approximately 2-4 days then undergo lens optimization, if required. Subjects will then be given a new pair of lenses that will be worn for approximately 2 weeks.
Primary Outcome
Overall vision scores were assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favor
Conditions Studied
Interventions
- DEVICE JJV Investigational Multifocal Contact Lens
- DEVICE ACUVUE OASYS® with HYDRACLEAR® PLUS
Study Locations (11)
Florida
- Dr. James Weber & Associates, PA - Jacksonville
- Sabal Eye Care - Longwood
- Maitland Vision Center - Maitland
Georgia
- VisualEyes - Roswell
Illinois
- VisionPoint Eye Center - Bloomington
Kansas
- Kannarr Eye Care - Pittsburg
Missouri
- Advanced Eyecare - Raytown
New York
- Sacco Eye Group - Vestal
Ohio
- ProCare Vision Centers - Granville
Rhode Island
- Dr. David W. Ferris & Associates - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2020-09-29 |
| Phase | NA |
What the finished NCT04534517 record still lists
NCT04534517 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 134-participant average among 20 other Visual Acuity trials with a reported enrollment target (11% lower).
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which JJV Investigational Multifocal Contact Lens is the first listed.
NCT04534517 lists 11 locations in 9 states (Florida, Georgia, Illinois).
Frequently Asked Questions
What is clinical trial NCT04534517 about?
NCT04534517 is a clinical study titled "Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population". The clinical study is a bilateral, single-masked (partial), single-arm, clinical trial. A total of approximately 60 eligible subjects both near-sighted and far-sighted, will be targeted to complete the study. Subjects will be fit in the study lens for approximately 2-4 days then undergo lens optimiz...
What is the current status of trial NCT04534517?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2020-08-07. Estimated completion is 2020-09-29.
What conditions does trial NCT04534517 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT04534517?
The interventions under investigation include: JJV Investigational Multifocal Contact Lens (DEVICE), ACUVUE OASYS® with HYDRACLEAR® PLUS (DEVICE).
Who is sponsoring clinical trial NCT04534517?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04534517 being conducted?
This trial has 11 study locations across Florida, Georgia, Illinois, Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04534517's enrollment target sits among peer trials
119 9th of 20 higher than 12 of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI